文献速递肝病

药物性肝损伤发病2年内的死亡与肝移植

Death and liver transplantation within 2 years of onset of drug-induced liver injury.
PubMed 文献 · Hepatology · 2017-08-26

美国药物性肝损伤网络前瞻性研究纳入1089例患者,2年内107例(9.8%)死亡,其中药物性肝损伤起主要作用68例(64%)、促进作用15例(14%)、无作用22例(21%)。新R比值Hy法则对总体死亡的阳性预测值高于原版Hy法则(14% vs 10%),且与26周内药物性肝损伤死亡独立关联更强(HR 6.2,95%CI 3.4-11.1 vs HR 2.2,95%CI 1.3-3.7)。

要点

  • 药物性肝损伤发病2年内死亡107/1089例(9.8%),其中64%死亡由药物性肝损伤起主要作用。
  • 主要作用死亡病例中74%为急性肝衰竭,13%为慢性,7%为慢加急性,6%为急性胆汁淤积性肝衰竭。
  • 新R比值Hy法则对总体死亡的阳性预测值为14%,原版Hy法则为10%。

核心结论

  • 药物性肝损伤直接或间接导致7.6%的病例死亡,其中40%为非急性肝衰竭病程。
  • 新R比值Hy法则较原版Hy法则能更好地识别死亡风险。

研究设计与样本

  • 美国药物性肝损伤网络前瞻性研究,纳入1089例患者,分析发病2年内出现死亡结局的病例。
  • 每例由8名网络研究者审阅,将药物性肝损伤在死亡中的作用分为主要、促进或无作用。

主要发现

  • 1089例中107例(9.8%)在2年内死亡。
  • 药物性肝损伤起主要作用68例(64%),促进作用15例(14%),无作用22例(21%),2例数据不足。
  • 主要作用病例中74%为急性肝衰竭,13%为慢性,7%为慢加急性,6%为急性胆汁淤积性肝衰竭。
  • 促进作用15例中常见死因为脓毒症、恶性肿瘤和伴多器官衰竭的严重皮肤反应;无作用22例中恶性肿瘤占多数。
  • 较高的胆红素、凝血功能障碍、白细胞增多和血小板减少与药物性肝损伤死亡独立相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Drug-induced liver injury (DILI) is an important cause of death and indication for liver transplantation (fatality). The role of DILI in these fatalities is poorly characterized, particularly when fatalities occur >26 weeks after DILI onset. We analyzed patients in the US Drug-Induced Liver Injury Network prospective study having a fatal outcome within 2 years of onset. Each case was reviewed by eight network investigators and categorized as DILI having a primary, a contributory, or no role in the fatality. We subcategorized primary role cases as acute, chronic, acute-on-chronic, or acute cholestatic liver failure. For contributory and no role cases, we assigned a primary cause of death. Among 1,089 patients, 107 (9.8%) fatalities occurred within 2 years. DILI had a primary role in 68 (64%), a contributory role in 15 (14%), and no role in 22 (21%); 2 had insufficient data. Among primary role cases, 74% had acute, 13% chronic, 7% acute on chronic, and 6% acute cholestatic failure. For the 15 contributory role cases, common causes of death included sepsis, malignancy, and severe cutaneous reactions with multiorgan failure. For the 22 no role cases, malignancies accounted for most fatalities. Higher bilirubin, coagulopathy, leukocytosis, and thrombocytopenia were independently associated with DILI fatalities. New R ratio Hy's law had a higher positive predictive value for overall fatality (14% versus 10%) and a stronger independent association with DILI fatalities within 26 weeks compared to the original version of Hy's law (hazard ratio, 6.2, 95% confidence interval 3.4-11.1, versus 2.2, 95% confidence interval 1.3-3.7). CONCLUSIONS: DILI leads directly or indirectly to fatality in 7.6% of cases; 40% of these had nonacute liver failure courses. New R ratio Hy's law better identifies risk for death compared to the original Hy's law. (Hepatology 2017;66:1275-1285).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Hayashi PH, Rockey DC, Fontana RJ, et al. Death and liver transplantation within 2 years of onset of drug-induced liver injury. Hepatology. 2017. PMID: 28543844. doi:10.1002/hep.29283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。